Trials / Unknown
UnknownNCT00354796
The Effect of Reduced Dose of Enoxaparin on the Outcomes of Treatment With Enoxaparin
The Effect of Reduced Dose of Enoxaparin on the Laboratory and Clinical Outcomes of Treatment With Enoxaparin
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 500 (estimated)
- Sponsor
- Hadassah Medical Organization · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
We hypothesize that reduced dose of enoxaparin in elderly patients will result in reduced proportion of patients with therapeutic anti Xa activity and reduced clinical efficacy.
Detailed description
Patients treated with enoxaparin will be followed, sociodemographic , clinical and laboratory data will be collected. Clinical efficacy as well as adverse events will be monitored.
Conditions
Timeline
- Start date
- 2006-07-01
- Completion
- 2015-10-01
- First posted
- 2006-07-20
- Last updated
- 2011-07-06
Locations
1 site across 1 country: Israel
Source: ClinicalTrials.gov record NCT00354796. Inclusion in this directory is not an endorsement.